imatinib (Compound)

Synonyms:Imatinib, 152459-95-5, STI571, Imatinib (STI571), Imatinib free base, N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide, Cgp 57148, Glamox, STI 571, Imatinib (INN), Imatinib Methansulfonate, 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE, CGP-57148, 152459-95-5 (free base), BKJ8M8G5HI, 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide, CHEMBL941, NSC-743414, NSC-759854, CHEBI:45783, MFCD05662257, NSC743414, N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide, IMATINIB [INN], Imatinib [INN:BAN], 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide, 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide, Benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-, STI, alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, Glamox (TN), CCRIS 9076, SR-01000763561, NCGC00159456-02, UNII-BKJ8M8G5HI, ST1571, ST 1571, imatinib-CD3, 1iep, 1xbb, Gleevec(TM), 4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl)-benzamide, 4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide, Imatinib (Gleevec), Imatinib - Gleevec, Imatinib, 21, Imatinib, Free base, alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide, Kinome_3724, 112GI019, IMATINIB [MI], IMATINIB [VANDF], IMATINIB [WHO-DD], Gleevec (TN) (Novartis), cid_5291, SCHEMBL3827, IMATINIB [EMA EPAR], STI-571; IMATINIB, BIDD:GT0047, GTPL5687, DTXSID3037125, BDBM13530, EX-A063, BCPP000205, CGP057148B, HMS2089D03, HMS3244P06, HMS3244P10, HMS3244P14, HMS3656K04, HMS3715P03, Pharmakon1600-01502276, BCP01542, AC-524, NSC759854, NSC800772, STK617705, VCC905240, AKOS000280662, BCP9000775, CCG-101289, CS-0964, DB00619, ES-0058, NSC 743414, NSC 759854, NSC-800772, SB17306, ST-1571, MRF-0000449, NCGC00159456-01, NCGC00159456-03, NCGC00159456-04, NCGC00159456-05, NCGC00159456-06, NCGC00159456-07, NCGC00159456-09, NCGC00159456-16, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate, 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide, BI164570, HY-15463, N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide, N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide, N-[4-Methyl-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide, SY028029, AM20090646, FT-0651483, I0906, S2475, SW197805-5, D08066, EN300-123057, AB00698388-07, AB00698388-10, AB00698388-11, AB00698388-12, AB00698388-13, AB00698388_15, AB00698388_16, A809313, Q177094, Q-201231, SR-01000763561-4, SR-01000763561-6, BRD-K92723993-066-02-9, BRD-K92723993-066-04-5, Z1546624232, 1080014-82-9, 4-(4-Me-piperazin-1-ylmethyl)-N-[4-Me-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3- pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-n[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide, BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINOPHENYL)-, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- (9CI), methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide

Pubchem:PUBCHEM:5291

Id:e00bdfef-adb6-5c02-bb22-ad54a18df5cc

Description:nan